• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼睑皮脂腺癌中CTNNB1基因及ras通路基因KRAS、NRAS、BRAF和PIK3CA的突变分析

Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.

作者信息

Kwon Mi Jung, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Choe Ji-Young

机构信息

Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang-si, Gyeonggi-do 431-070, Republic of Korea.

Department of Pathology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 134-701, Republic of Korea.

出版信息

Pathol Res Pract. 2017 Jun;213(6):654-658. doi: 10.1016/j.prp.2017.02.015. Epub 2017 Mar 1.

DOI:10.1016/j.prp.2017.02.015
PMID:28551389
Abstract

Sebaceous carcinoma (SC) represents a rare, aggressive eyelid malignancy with poor prognosis and is a possible component of Muir-Torre syndrome. However, genetic features as driver mutations or potential therapeutic targets are not fully elucidated. Recent a few studies have shown that SCs have concurrently multiple mutations including RAS/RAF/MAPK and PI3K/Akt pathways via next-generation sequencing in western population. Because we recently demonstrated absence of KRAS mutations in Korean eyelid SCs, we extended our previous study to the analysis of NRAS, BRAF, PIK3CA, and CTNNB1 mutations, and the examination of related protein expressions in 15 eyelid SCs. Repeated molecular analysis by peptide nucleic acid-mediated PCR clamping method, PNA clamping-assisted fluorescence melting curve analysis, and direct sequencing revealed that all eyelid SCs had wild type alleles of NRAS, BRAF, and PIK3CA in hotspot exon locations. Only silent mutations in the CTNNB1 gene (p.Q61Q) were identified. Using immunohistochemistry and microsatellite instability analysis, they harbored all intact mismatch repair gene proteins with microsatellite stability. Membranous and cytoplasmic β-catenin staining was found in all tumors, whereas the one third of those tumors showed cyclin D1 overexpression, of which 40% and 80% showed p53 expression and p16 expression, respectively. The lack of KRAS, NRAS, BRAF, and PIK3CA mutation in our study may suggest that a subset of eyelid SCs is unlike that of eyelid SCs of western countries. The mismatch repair gene proteins and microsatellite instability analysis as a screening test for Muir-Torre syndrome may be limited in the Korean eyelid SCs.

摘要

皮脂腺癌(SC)是一种罕见的侵袭性眼睑恶性肿瘤,预后较差,是穆尔-托里综合征的可能组成部分。然而,作为驱动突变或潜在治疗靶点的基因特征尚未完全阐明。最近的一些研究表明,在西方人群中,通过二代测序发现皮脂腺癌同时存在包括RAS/RAF/MAPK和PI3K/Akt通路在内的多种突变。由于我们最近证明韩国眼睑皮脂腺癌不存在KRAS突变,因此我们将之前的研究扩展至对15例眼睑皮脂腺癌中NRAS、BRAF、PIK3CA和CTNNB1突变的分析以及相关蛋白表达的检测。通过肽核酸介导的PCR钳夹法、PNA钳夹辅助荧光熔解曲线分析和直接测序进行的重复分子分析显示,所有眼睑皮脂腺癌在热点外显子位置均具有NRAS、BRAF和PIK3CA的野生型等位基因。仅鉴定出CTNNB1基因的沉默突变(p.Q61Q)。通过免疫组织化学和微卫星不稳定性分析,它们均具有完整的错配修复基因蛋白且微卫星稳定。在所有肿瘤中均发现膜性和细胞质β-连环蛋白染色,而其中三分之一的肿瘤显示细胞周期蛋白D1过表达,其中40%和80%的肿瘤分别显示p53表达和p16表达。我们研究中缺乏KRAS、NRAS、BRAF和PIK3CA突变可能表明一部分眼睑皮脂腺癌与西方国家的眼睑皮脂腺癌不同。错配修复基因蛋白和微卫星不稳定性分析作为穆尔-托里综合征的筛查试验在韩国眼睑皮脂腺癌中可能有限。

相似文献

1
Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.眼睑皮脂腺癌中CTNNB1基因及ras通路基因KRAS、NRAS、BRAF和PIK3CA的突变分析
Pathol Res Pract. 2017 Jun;213(6):654-658. doi: 10.1016/j.prp.2017.02.015. Epub 2017 Mar 1.
2
DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.眼周皮脂癌中的 DNA 错配修复缺陷和微卫星不稳定性状态。
Am J Ophthalmol. 2014 Mar;157(3):640-7.e1-2. doi: 10.1016/j.ajo.2013.12.002. Epub 2013 Dec 7.
3
Comparison of HER2 gene amplification and KRAS alteration in eyelid sebaceous carcinomas with that in other eyelid tumors.眼睑皮脂腺癌中HER2基因扩增和KRAS改变与其他眼睑肿瘤的比较。
Pathol Res Pract. 2015 May;211(5):349-55. doi: 10.1016/j.prp.2014.10.006. Epub 2014 Oct 27.
4
BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis.对错配修复蛋白分析后的皮脂肿瘤进行 BRAF/KRAS 基因测序。
Hum Pathol. 2014 Jun;45(6):1213-20. doi: 10.1016/j.humpath.2014.02.001. Epub 2014 Feb 20.
5
Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.下一代测序技术鉴定出了皮脂腺癌中潜在具有临床可操作性的基因突变的高频发生。
J Pathol. 2016 Sep;240(1):84-95. doi: 10.1002/path.4759.
6
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.KRAS、NRAS、BRAF和PIK3CA突变对原发性结直肠癌的预后影响:一项基于人群的研究。
J Transl Med. 2016 Oct 13;14(1):292. doi: 10.1186/s12967-016-1053-z.
7
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.错配修复基因存在2个或更多体细胞突变的结直肠癌和子宫内膜肿瘤中频繁出现的PIK3CA突变
Gastroenterology. 2016 Sep;151(3):440-447.e1. doi: 10.1053/j.gastro.2016.06.004. Epub 2016 Jun 11.
8
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.在一个大型局部晚期直肠癌患者前瞻性系列中分析 KRAS、NRAS、BRAF、PIK3CA 和 TP53 突变。
Int J Cancer. 2020 Jan 1;146(1):94-102. doi: 10.1002/ijc.32507. Epub 2019 Jul 5.
9
KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients.KRAS、NRAS、BRAF 和 PIK3CA 基因突变率、临床病理相关性及其在伊朗结直肠癌患者中的预后价值。
J Clin Lab Anal. 2023 Mar;37(5):e24868. doi: 10.1002/jcla.24868. Epub 2023 Mar 17.
10
[Combined detection of KRAS, NRAS, BRAF and PIK3CA mutations in the plasma and tumor tissues of colorectal cancer patients].[结直肠癌患者血浆与肿瘤组织中KRAS、NRAS、BRAF及PIK3CA基因突变的联合检测]
Zhonghua Bing Li Xue Za Zhi. 2019 May 8;48(5):373-377. doi: 10.3760/cma.j.issn.0529-5807.2019.05.008.

引用本文的文献

1
Epidemiology and tumor microenvironment of ocular surface and orbital tumors on growth and malignant transformation.眼表及眼眶肿瘤生长与恶变的流行病学及肿瘤微环境
Front Oncol. 2024 Oct 3;14:1388156. doi: 10.3389/fonc.2024.1388156. eCollection 2024.
2
Integrated Whole-Exome and Transcriptome Sequencing Indicated Dysregulation of Cholesterol Metabolism in Eyelid Sebaceous Gland Carcinoma.全外显子组和转录组测序表明胆固醇代谢失调与眼睑皮脂腺癌有关。
Transl Vis Sci Technol. 2023 Feb 1;12(2):4. doi: 10.1167/tvst.12.2.4.
3
Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.
确定与原始 WHO 分级相对应的磷酸组蛋白 H3 截断值,但在分化良好的胃肠神经内分泌肿瘤中可区分。
Biomed Res Int. 2018 Mar 27;2018:1013640. doi: 10.1155/2018/1013640. eCollection 2018.